What is Orthofix Medical Inc.'s market cap?

Orthofix Medical Inc. (OFIX) has a market capitalization of $370.3M and trades on NASDAQ.

What is Orthofix Medical Inc.'s revenue and profitability?

Orthofix Medical Inc. generated $833.2M in trailing twelve-month revenue with a net loss of $61.7M, representing a net margin of -7.4%. Gross margin stands at 71.3%, with free cash flow of -$73.0M. The latest reported period is Q2 2026.

Who are Orthofix Medical Inc.'s competitors?

Orthofix Medical Inc.'s key competitors include Globus Medical, Stryker, Alphatec Spine, and others. These companies compete in similar markets and product categories.

Who does Orthofix Medical Inc. partner with?

Orthofix Medical Inc.'s notable partners include MTF Biologics, MRIguidance.

What subsidiaries does Orthofix Medical Inc. have?

Orthofix Medical Inc.'s subsidiaries include SeaSpine Holdings Corporation, IsoTis Orthobiologics, Inc., Orthofix US LLC.

Where is Orthofix Medical Inc. headquartered?

Orthofix Medical Inc. is headquartered in United States of America and employs approximately 1,634 people. It has been publicly traded since 1992.

Orthofix Medical Inc. (OFIX) Stock Fundamentals & Financials

Orthofix Medical Inc. is a global medical technology company specializing in musculoskeletal pathologies and regenerative solutions.

Market cap

$370.26M-37.2%

Revenue$833.2M+3.0%

Net income-$61.7M+50.1%

Free cash flow-$73.0M+20.4%

EPS (diluted)-$1.53+51.7%

Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 5, 2026

Revenue$210.9MBeat by $1.7M EPS-$0.39Beat by $0.02

Read the full report

Next report

Nov 3, 2026 (in 2 months)

Revenue estimate$210.7M

EPS estimate$0.11

Financials

Q2 2026

Income statement

See full

Revenue$210.9M+3.8%

Gross profit$149.7M+7.3%

Operating income-$8.1M+49.2%

Net income-$15.8M-12.2%

EPS (diluted)-$0.39-8.3%

Balance sheet

See full

Cash & equivalents$103.8M+58.2%

Total debt$237.7M+33.3%

Total equity$429.2M-6.4%

Total assets$873.0M+4.3%

Cash flow

See full

Operating cash flow-$6.2M-153%

CapEx$12.6M+77.9%

Free cash flow-$18.9M—

Valuation & ratios

Valuation

See full

Market cap$370.26M-37.2%

Enterprise value$504.13M-27.9%

P/S0.4×-0.3×

Profitability

See full

Gross margin71.3%+3.9pp

Operating margin-4.8%-1.8pp

Net margin-7.4%-2.5pp

Returns & leverage

See full

Return on equity-13.9%-4.2pp

Debt / equity0.6×+0.2×

Current ratio2.8×+0.2×

Segments

By segment

See full

Global Spine$173.2M+2.0%

Global Limb Reconstruction$37.7M—

Competitors

By market cap

Johnson & Johnson$643.92B+51.5%

Medtronic$119.92B-0.7%

Stryker$107.98B-25.0%

Globus Medical$10.0B+28.4%

Alphatec Holdings$1.6B-26.0%

Enovis$1.0B-45.7%

Bioventus$888.0M+94.1%

Orthofix Medical Inc.$370.3M-36.8%

By revenue growth

Alphatec Holdings+22.6%

Globus Medical+19.7%

Medtronic+9.8%

Stryker+8.5%

Johnson & Johnson+8.1%

Enovis+4.9%

Bioventus+3.1%

Orthofix Medical Inc.+3.0%

By net margin

Johnson & Johnson21.48%-3.5pp

Globus Medical17.03%+3.5pp

Stryker14.43%+2.2pp

Medtronic13.93%+0.3pp

Bioventus9.36%+9.5pp

Orthofix Medical Inc.-7.41%+7.9pp

Alphatec Holdings-15.93%+9.8pp

Enovis-47.97%-10.2pp

Profile

Orthofix Medical Inc. is a global medical technology company specializing in musculoskeletal pathologies and regenerative solutions. The company provides a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, and biologics. Its core value proposition centers on delivering life-changing surgical and non-surgical solutions through proprietary technologies like pulsed electromagnetic field (PEMF) therapy and machine-vision surgical navigation.

Competitive position

A leading provider in the bone growth stimulation market and a significant player in spinal implants and limb reconstruction, distinguished by being the only manufacturer offering both PEMF and LIPUS technologies.

GeographiesUnited States, Italy, Canada, Germany, Spain, China

Customer segmentsOrthopedic Surgeons, Neurosurgeons, Healthcare Facilities

Business modelManufacturing, Direct Sales, Distributor Network, Capital Equipment Sales

SuppliersHuman tissue banks (AATB accredited), Bovine tissue suppliers, Specialized component manufacturers, Raw material suppliers (PEEK, Titanium, Stainless Steel)

CustomersHospitals, Ambulatory Surgery Centers, Specialty Orthopedic Clinics, Patients (for home-use stimulation devices)

CountryUnited States of America

Listed1992

Employees1.6K

CEOMassimo Calafiore

SectorHealthcare

IndustryMedical - Devices

Websiteorthofix.com

FilingsSEC EDGAR

FAQ

What is Orthofix Medical Inc.'s market cap?: Orthofix Medical Inc. (OFIX) has a market capitalization of $370.3M and trades on NASDAQ.
What is Orthofix Medical Inc.'s revenue and profitability?: Orthofix Medical Inc. generated $833.2M in trailing twelve-month revenue with a net loss of $61.7M, representing a net margin of -7.4%. Gross margin stands at 71.3%, with free cash flow of -$73.0M. The latest reported period is Q2 2026.
Who are Orthofix Medical Inc.'s competitors?: Orthofix Medical Inc.'s key competitors include Globus Medical, Stryker, Alphatec Spine, and others. These companies compete in similar markets and product categories.
Who does Orthofix Medical Inc. partner with?: Orthofix Medical Inc.'s notable partners include MTF Biologics, MRIguidance.
What subsidiaries does Orthofix Medical Inc. have?: Orthofix Medical Inc.'s subsidiaries include SeaSpine Holdings Corporation, IsoTis Orthobiologics, Inc., Orthofix US LLC.
Where is Orthofix Medical Inc. headquartered?: Orthofix Medical Inc. is headquartered in United States of America and employs approximately 1,634 people. It has been publicly traded since 1992.

Ask your AI about Orthofix Medical Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude